Acyclovir

From IDWiki
Revision as of 14:01, 12 August 2020 by Aidan (talk | contribs) (Created page with "* Acyclic guanosine analog that competes with deoxyguanosine triphosphate to inhibit viral DNA polymerase * Resistance mediated by mutation in or decrease of thymidine kinase...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
  • Acyclic guanosine analog that competes with deoxyguanosine triphosphate to inhibit viral DNA polymerase
  • Resistance mediated by mutation in or decrease of thymidine kinase
  • Adverse drug reactions include:
    • AKI from crystal deposition, so maintain hydration
    • Phlebitis
    • Neurotoxicity, with lethargy, confusion, tremor, myoclonus, agitation, hallucinations, and extrapyramidal symptoms

References

  1. ^  Tony H. Huynh, Mark W. Johnson, Grant M. Comer, Douglas N. Fish. Vitreous Penetration of Orally Administered Valacyclovir. American Journal of Ophthalmology. 2008;145(4):682-686. doi:10.1016/j.ajo.2007.11.016.